Crohn’s and Colitis Canada Links IBD Research with Patient Care in Vital Expansion Network

Crohn’s and Colitis Canada Links IBD Research with Patient Care in Vital Expansion Network
Crohn’s and Colitis Canada announced that its pioneering work to bridge pan-Canadian inflammatory bowel disease (IBD) research with patient care is moving forward with the launch of a Strategy for Patient-Oriented Research (SPOR) proposal for the IMAGINE network. "Crohn's and Colitis Canada's commitment to fundamental and clinical research in IBD over the years has built incredible scientific capacity and excellence," Mina Mawani, Crohn’s and Colitis Canada’s president and CEO, said in a press release. "We are delighted that our support has positioned our IBD research community for success in securing greater government investment in gastrointestinal (GI) research, and that we will participate in this innovative network to ensure the research will lead to patient benefits and improved outcomes." Crohn’s and Colitis Canada is a founding partner of the new enterprise and has  been a significant supporter and influencer of the new SPOR project. IMAGINE (Inflammation, Microbiome and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects Network) will fill the gap between the lab and the doctor’s office by fostering evidence-based healthcare and bring it to the patient. "Canada has among the highest reported prevalence of Crohn's disease, ulcerative colitis, and irritable bowel syndrome in the world," said Dr. Paul Moayyedi, IMAGINE’s lead researcher. "It is vital that we begin a process where we can integrate research from across the countr
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *